Effect of calcium channel antagonists on the cardiac vagal tone response to submaximal exercise
Reductions in cardiac vagal tone have been shown to correlate with a greater susceptibility to ventricular fibrillation. Calcium antagonists have been shown to protect against malignant arrhythmias probably as the result of direct actions on cardiac muscle. However, these drugs could also reflexivel...
Gespeichert in:
Veröffentlicht in: | Drug development research 1992, Vol.27 (2), p.89-106 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 106 |
---|---|
container_issue | 2 |
container_start_page | 89 |
container_title | Drug development research |
container_volume | 27 |
creator | Billman, George E. Halliwill, John R. Avendano, Christopher E. |
description | Reductions in cardiac vagal tone have been shown to correlate with a greater susceptibility to ventricular fibrillation. Calcium antagonists have been shown to protect against malignant arrhythmias probably as the result of direct actions on cardiac muscle. However, these drugs could also reflexively alter cardiac vagal tone as a consequence of reductions in arterial pressure. Therefore, the effects of various calcium channel antagonists on cardiac vagal tone, both at rest and during exercise, were investigated. The R‐R interval was recorded in chronically instrumented mongrel dogs (n = 39) and the amplitude of the respiratory sinus arrhythmia (0.24–1.04 Hz) was calculated using time‐series analysis techniques. Before exercise, verapamil (n = 17, 250 μg/kg), nifedipine (n = 5, 10 μg/kg; n = 9, 100 μg/kg), diltiazem (n = 10, 100 mg/kg), Ro 40‐5967 (n = 14, 1,000 μg/kg), and magnesium sulfate (n = 10, 100 mg/kg) significantly increased heart rate, while flunarizine (n = 11, 2.5 mg/kg) and a lower dose of Ro 40‐5967 (n = 5, 250 μg/kg) did not affect heart rate. During exercise, nifedipine (high dose) increased heart rate, while Ro 40‐5967 (high dose) decreased heart rate. All six drugs reduced vagal tone before exercise; magnesium and nifedipine (high dose) elicited the greatest reduction, while flunarizine produced the smallest decrease. The vagal tone response to exercise was not affected by flunarizine and Ro 40‐5967 (low dose), but it was accentuated by magnesium, nifedipine, and verapamil. Intermediate responses were noted for Ro‐40‐5967 (high dose) and diltiazem. Pronounced hemodynamic effects were noted for flunarizine, magnesium, nifedipine, and verapamil, but not for Ro 40‐5967. Thus, calcium antagonists have variable hemodynamic profiles and can elicit pronounced reductions in cardiac vagal tone, presumably due to activation of the baroreceptor reflex. © 1992 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/ddr.430270203 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16816287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16816287</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3813-3f27c3ad4848ebcb3eb82bf6245007aef0f6a2efa2d120d407ebe676c40dee1e3</originalsourceid><addsrcrecordid>eNp9kE1PGzEQhq2qSKTAkbsPVW9Lxx9ZO8eWj1AVgYQoHK1Z7xi23XhTewPh39dVoogTJ2vsZ17PPIwdCzgRAPJr26YTrUAakKA-sImAma2knM0-skm5lZVWM7HPPuX8G0AIbe2EufMQyI98CNxj77vVgvsnjJF6jnHExyF2ecx8iHx8ooKktkPPn_ERez4OkXiivBxiplLxvGoWuO4W5Y3WlHyX6ZDtBewzHW3PA_br4vzu9LK6upn_OP12VXllhapUkMYrbLXVlhrfKGqsbEIt9RTAIAUINUoKKFshodVgqKHa1F5DSyRIHbAvm9xlGv6uKI9u0WVPfY-RhlV2orailtYUsNqAPg05JwpumcrE6dUJcP81uqLR7TQW_vM2GHMxFBLGsteuSSszFdO6YGaDvXQ9vb6f6c7Obt9-sB2oiKb1rhPTH1ebku4erufu-ifcf7-8m7sH9Q_iGJOD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16816287</pqid></control><display><type>article</type><title>Effect of calcium channel antagonists on the cardiac vagal tone response to submaximal exercise</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Billman, George E. ; Halliwill, John R. ; Avendano, Christopher E.</creator><creatorcontrib>Billman, George E. ; Halliwill, John R. ; Avendano, Christopher E.</creatorcontrib><description>Reductions in cardiac vagal tone have been shown to correlate with a greater susceptibility to ventricular fibrillation. Calcium antagonists have been shown to protect against malignant arrhythmias probably as the result of direct actions on cardiac muscle. However, these drugs could also reflexively alter cardiac vagal tone as a consequence of reductions in arterial pressure. Therefore, the effects of various calcium channel antagonists on cardiac vagal tone, both at rest and during exercise, were investigated. The R‐R interval was recorded in chronically instrumented mongrel dogs (n = 39) and the amplitude of the respiratory sinus arrhythmia (0.24–1.04 Hz) was calculated using time‐series analysis techniques. Before exercise, verapamil (n = 17, 250 μg/kg), nifedipine (n = 5, 10 μg/kg; n = 9, 100 μg/kg), diltiazem (n = 10, 100 mg/kg), Ro 40‐5967 (n = 14, 1,000 μg/kg), and magnesium sulfate (n = 10, 100 mg/kg) significantly increased heart rate, while flunarizine (n = 11, 2.5 mg/kg) and a lower dose of Ro 40‐5967 (n = 5, 250 μg/kg) did not affect heart rate. During exercise, nifedipine (high dose) increased heart rate, while Ro 40‐5967 (high dose) decreased heart rate. All six drugs reduced vagal tone before exercise; magnesium and nifedipine (high dose) elicited the greatest reduction, while flunarizine produced the smallest decrease. The vagal tone response to exercise was not affected by flunarizine and Ro 40‐5967 (low dose), but it was accentuated by magnesium, nifedipine, and verapamil. Intermediate responses were noted for Ro‐40‐5967 (high dose) and diltiazem. Pronounced hemodynamic effects were noted for flunarizine, magnesium, nifedipine, and verapamil, but not for Ro 40‐5967. Thus, calcium antagonists have variable hemodynamic profiles and can elicit pronounced reductions in cardiac vagal tone, presumably due to activation of the baroreceptor reflex. © 1992 Wiley‐Liss, Inc.</description><identifier>ISSN: 0272-4391</identifier><identifier>EISSN: 1098-2299</identifier><identifier>DOI: 10.1002/ddr.430270203</identifier><identifier>CODEN: DDREDK</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological and medical sciences ; Cardiovascular system ; heart rate variability ; Medical sciences ; Miscellaneous ; parasympathetic activity ; Pharmacology. Drug treatments ; time-series analysis</subject><ispartof>Drug development research, 1992, Vol.27 (2), p.89-106</ispartof><rights>Copyright © 1992 Wiley‐Liss, Inc.</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3813-3f27c3ad4848ebcb3eb82bf6245007aef0f6a2efa2d120d407ebe676c40dee1e3</citedby><cites>FETCH-LOGICAL-c3813-3f27c3ad4848ebcb3eb82bf6245007aef0f6a2efa2d120d407ebe676c40dee1e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fddr.430270203$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fddr.430270203$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,4010,27900,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4375156$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Billman, George E.</creatorcontrib><creatorcontrib>Halliwill, John R.</creatorcontrib><creatorcontrib>Avendano, Christopher E.</creatorcontrib><title>Effect of calcium channel antagonists on the cardiac vagal tone response to submaximal exercise</title><title>Drug development research</title><addtitle>Drug Dev. Res</addtitle><description>Reductions in cardiac vagal tone have been shown to correlate with a greater susceptibility to ventricular fibrillation. Calcium antagonists have been shown to protect against malignant arrhythmias probably as the result of direct actions on cardiac muscle. However, these drugs could also reflexively alter cardiac vagal tone as a consequence of reductions in arterial pressure. Therefore, the effects of various calcium channel antagonists on cardiac vagal tone, both at rest and during exercise, were investigated. The R‐R interval was recorded in chronically instrumented mongrel dogs (n = 39) and the amplitude of the respiratory sinus arrhythmia (0.24–1.04 Hz) was calculated using time‐series analysis techniques. Before exercise, verapamil (n = 17, 250 μg/kg), nifedipine (n = 5, 10 μg/kg; n = 9, 100 μg/kg), diltiazem (n = 10, 100 mg/kg), Ro 40‐5967 (n = 14, 1,000 μg/kg), and magnesium sulfate (n = 10, 100 mg/kg) significantly increased heart rate, while flunarizine (n = 11, 2.5 mg/kg) and a lower dose of Ro 40‐5967 (n = 5, 250 μg/kg) did not affect heart rate. During exercise, nifedipine (high dose) increased heart rate, while Ro 40‐5967 (high dose) decreased heart rate. All six drugs reduced vagal tone before exercise; magnesium and nifedipine (high dose) elicited the greatest reduction, while flunarizine produced the smallest decrease. The vagal tone response to exercise was not affected by flunarizine and Ro 40‐5967 (low dose), but it was accentuated by magnesium, nifedipine, and verapamil. Intermediate responses were noted for Ro‐40‐5967 (high dose) and diltiazem. Pronounced hemodynamic effects were noted for flunarizine, magnesium, nifedipine, and verapamil, but not for Ro 40‐5967. Thus, calcium antagonists have variable hemodynamic profiles and can elicit pronounced reductions in cardiac vagal tone, presumably due to activation of the baroreceptor reflex. © 1992 Wiley‐Liss, Inc.</description><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>heart rate variability</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>parasympathetic activity</subject><subject>Pharmacology. Drug treatments</subject><subject>time-series analysis</subject><issn>0272-4391</issn><issn>1098-2299</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><recordid>eNp9kE1PGzEQhq2qSKTAkbsPVW9Lxx9ZO8eWj1AVgYQoHK1Z7xi23XhTewPh39dVoogTJ2vsZ17PPIwdCzgRAPJr26YTrUAakKA-sImAma2knM0-skm5lZVWM7HPPuX8G0AIbe2EufMQyI98CNxj77vVgvsnjJF6jnHExyF2ecx8iHx8ooKktkPPn_ERez4OkXiivBxiplLxvGoWuO4W5Y3WlHyX6ZDtBewzHW3PA_br4vzu9LK6upn_OP12VXllhapUkMYrbLXVlhrfKGqsbEIt9RTAIAUINUoKKFshodVgqKHa1F5DSyRIHbAvm9xlGv6uKI9u0WVPfY-RhlV2orailtYUsNqAPg05JwpumcrE6dUJcP81uqLR7TQW_vM2GHMxFBLGsteuSSszFdO6YGaDvXQ9vb6f6c7Obt9-sB2oiKb1rhPTH1ebku4erufu-ifcf7-8m7sH9Q_iGJOD</recordid><startdate>1992</startdate><enddate>1992</enddate><creator>Billman, George E.</creator><creator>Halliwill, John R.</creator><creator>Avendano, Christopher E.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope></search><sort><creationdate>1992</creationdate><title>Effect of calcium channel antagonists on the cardiac vagal tone response to submaximal exercise</title><author>Billman, George E. ; Halliwill, John R. ; Avendano, Christopher E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3813-3f27c3ad4848ebcb3eb82bf6245007aef0f6a2efa2d120d407ebe676c40dee1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>heart rate variability</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>parasympathetic activity</topic><topic>Pharmacology. Drug treatments</topic><topic>time-series analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Billman, George E.</creatorcontrib><creatorcontrib>Halliwill, John R.</creatorcontrib><creatorcontrib>Avendano, Christopher E.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><jtitle>Drug development research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Billman, George E.</au><au>Halliwill, John R.</au><au>Avendano, Christopher E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of calcium channel antagonists on the cardiac vagal tone response to submaximal exercise</atitle><jtitle>Drug development research</jtitle><addtitle>Drug Dev. Res</addtitle><date>1992</date><risdate>1992</risdate><volume>27</volume><issue>2</issue><spage>89</spage><epage>106</epage><pages>89-106</pages><issn>0272-4391</issn><eissn>1098-2299</eissn><coden>DDREDK</coden><abstract>Reductions in cardiac vagal tone have been shown to correlate with a greater susceptibility to ventricular fibrillation. Calcium antagonists have been shown to protect against malignant arrhythmias probably as the result of direct actions on cardiac muscle. However, these drugs could also reflexively alter cardiac vagal tone as a consequence of reductions in arterial pressure. Therefore, the effects of various calcium channel antagonists on cardiac vagal tone, both at rest and during exercise, were investigated. The R‐R interval was recorded in chronically instrumented mongrel dogs (n = 39) and the amplitude of the respiratory sinus arrhythmia (0.24–1.04 Hz) was calculated using time‐series analysis techniques. Before exercise, verapamil (n = 17, 250 μg/kg), nifedipine (n = 5, 10 μg/kg; n = 9, 100 μg/kg), diltiazem (n = 10, 100 mg/kg), Ro 40‐5967 (n = 14, 1,000 μg/kg), and magnesium sulfate (n = 10, 100 mg/kg) significantly increased heart rate, while flunarizine (n = 11, 2.5 mg/kg) and a lower dose of Ro 40‐5967 (n = 5, 250 μg/kg) did not affect heart rate. During exercise, nifedipine (high dose) increased heart rate, while Ro 40‐5967 (high dose) decreased heart rate. All six drugs reduced vagal tone before exercise; magnesium and nifedipine (high dose) elicited the greatest reduction, while flunarizine produced the smallest decrease. The vagal tone response to exercise was not affected by flunarizine and Ro 40‐5967 (low dose), but it was accentuated by magnesium, nifedipine, and verapamil. Intermediate responses were noted for Ro‐40‐5967 (high dose) and diltiazem. Pronounced hemodynamic effects were noted for flunarizine, magnesium, nifedipine, and verapamil, but not for Ro 40‐5967. Thus, calcium antagonists have variable hemodynamic profiles and can elicit pronounced reductions in cardiac vagal tone, presumably due to activation of the baroreceptor reflex. © 1992 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><doi>10.1002/ddr.430270203</doi><tpages>18</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0272-4391 |
ispartof | Drug development research, 1992, Vol.27 (2), p.89-106 |
issn | 0272-4391 1098-2299 |
language | eng |
recordid | cdi_proquest_miscellaneous_16816287 |
source | Wiley Online Library Journals Frontfile Complete |
subjects | Biological and medical sciences Cardiovascular system heart rate variability Medical sciences Miscellaneous parasympathetic activity Pharmacology. Drug treatments time-series analysis |
title | Effect of calcium channel antagonists on the cardiac vagal tone response to submaximal exercise |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T12%3A13%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20calcium%20channel%20antagonists%20on%20the%20cardiac%20vagal%20tone%20response%20to%20submaximal%20exercise&rft.jtitle=Drug%20development%20research&rft.au=Billman,%20George%20E.&rft.date=1992&rft.volume=27&rft.issue=2&rft.spage=89&rft.epage=106&rft.pages=89-106&rft.issn=0272-4391&rft.eissn=1098-2299&rft.coden=DDREDK&rft_id=info:doi/10.1002/ddr.430270203&rft_dat=%3Cproquest_cross%3E16816287%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16816287&rft_id=info:pmid/&rfr_iscdi=true |